Johanna Olweus

1965 -

country of citizenship: Norway

educated at: University of Bergen

occupation: physician, professor, researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 44

Date

Title

Authors

2022-03-09

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

Julien Champagne, Onno B Bleijerveld, Domenica Lovecchio, George Georgiou, Mark C de Gooijer, Olaf van Tellingen, Robbie P. Joosten, Anastassis Perrakis, Johanna Olweus, Michal Bassani-Sternberg, Daniel Peeper, Reuven Agami
2021-12-06

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes

Marieke Griffioen, Jochen Buechner, Kenan Garcia, Ton Schumacher, Peter van Veelen, Matthias Leisegang, Petter S. Woll, Johanna Olweus
2019-07-01

Finding Neo (antigens, that is)

Fridtjof Lund-Johansen, Johanna Olweus
2019-05-17

Induction of neoantigen-reactive T cells from healthy donors

Ton Schumacher, Oliver Kohlbacher, Johanna Olweus
2018-02-19

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors

Vincent Y S Oei, Agnieszka Graczyk-Jarzynka, Malgorzata Bajor, Radosław Zagożdżon, Karl-Johan Malmberg, Marta Siernicka, Johanna Olweus
2017-05-02

Defective IL-4 signaling in T cells defines severe common variable immunodeficiency

Pål Aukrust, Kjetil Taskén, June H. Myklebust, Johanna Olweus
2017-12-11

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.

Johanna Olweus
2017-06-01

Manufacture of CAR-T cells in the body.

Johanna Olweus
2016-05-19

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

Marco Donia, Fridtjof Lund-Johansen, Ton Schumacher, Johanna Olweus
2016-02-18

Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA

Sébastien Wälchli, Karl-Johan Malmberg, Arne Kolstad, Johanna Olweus, Nadia Mensali, Shraddha Kumari, Even Walseng, Lars-Egil Fallang
2016-12-02

Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency

Ole Christian Lingjærde, Pål Aukrust, June H. Myklebust, Johanna Olweus
2015-10-20

T-cell receptor gene therapy--ready to go viral?

Terhi Karpanen, Johanna Olweus
2015-04-13

Soluble T-cell receptors produced in human cells for targeted delivery

Sébastien Wälchli, Johanna Olweus, Even Walseng, Lars-Egil Fallang
2015-06-13

Unpredicted phenotypes of two mutants of the TcR DMF5.

Fitsum G Tadesse, Sébastien Wälchli, Johanna Olweus, Nadia Mensali, Even Walseng, Lars-Egil Fallang
2015-03-19

"In situ" vaccination for systemic effects in follicular lymphoma

Arne Kolstad, Johanna Olweus
2015-10-30

Cancer immunotherapy--Converting immune failure to clinical response

Johanna Olweus
2014-03-01

Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

Pål Aukrust, Stig Frøland, Johanna Olweus
2014-10-07

Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma.

Jan Delabie, Anne Tierens, Harald Holte, Gunnar Kvalheim, Arne Kolstad, Johanna Olweus, Trond Velde Bogsrud, Shraddha Kumari
2013-12-16

Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes

Sébastien Wälchli, Fridtjof Lund-Johansen, Ton Schumacher, Johanna Olweus, Shraddha Kumari, Lars-Egil Fallang
2013-12-27

Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation

Oddmund Bakke, Sébastien Wälchli, Ole J B Landsverk, Johanna Olweus, Shraddha Kumari, Lars-Egil Fallang
2012-04-01

[Can the immune system target cancer?]

Arne Kolstad, Johanna Olweus
2011-11-21

A practical approach to T-cell receptor cloning and expression

Geir Åge Løset, Inger Sandlie, Sébastien Wälchli, Johanna Olweus, Shraddha Kumari
2011-08-12

T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells.

Arne Kolstad, Sébastien Wälchli, Margrethe Greve-Isdahl, Johanna Olweus, Nadia Mensali, Shraddha Kumari
2010-09-16

Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif

Sébastien Wälchli, Fridtjof Lund-Johansen, Gustav Gaudernack, Geir Erland Tjønnfjord, Johanna Olweus, Ton Schumacher
2009-04-01

Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells

Sébastien Wälchli, Else Munthe, Soren Buus, Fridtjof Lund-Johansen, Gustav Gaudernack, Johanna Olweus
2007-01-01

Assay for monitoring in vitro selective depletion strategies in allogeneic stem cell transplantation

Fridtjof Lund-Johansen, Johanna Olweus
2006-12-07

Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells

Fridtjof Lund-Johansen, Johanna Olweus, Lorant Farkas
2005-11-03

CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection

Fridtjof Lund-Johansen, Johanna Olweus, Lorant Farkas
1999-04-01

Primitive human hematopoietic progenitor cells express receptors for granulocyte-macrophage colony-stimulating factor

Fridtjof Lund-Johansen, Johanna Olweus
1999-06-01

[Dendritic cells--strong candidates for immunotherapy]

Fridtjof Lund-Johansen, Johanna Olweus
1997-11-01

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin

Fridtjof Lund-Johansen, Johanna Olweus
1996-11-01

Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU.1-regulated molecules, CD64 and macrophage colony-stimulating factor receptor.

Fridtjof Lund-Johansen, Johanna Olweus

Human - wd:Q17106319

Welcome to Inventaire

the library of your friends and communities

learn more